Harvard Bioscience (HBIO)
(Delayed Data from NSDQ)
$3.62 USD
+0.06 (1.69%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.63 +0.01 (0.28%) 6:50 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 4/30/24 |
---|---|
Current Quarter | 0.06 |
EPS Last Quarter | 0.04 |
Last EPS Surprise | -20.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.23 |
Next Year | NA |
EPS (TTM) | 0.15 |
P/E (F1) | 15.82 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 25.78M | 29.91M | 118.80M | 135.00M |
# of Estimates | 1 | 1 | 2 | 1 |
High Estimate | 25.78M | 29.91M | 121.00M | 135.00M |
Low Estimate | 25.78M | 29.91M | 116.60M | 135.00M |
Year ago Sales | 29.98M | 28.76M | 112.25M | 118.80M |
Year over Year Growth Est. | -14.01% | 4.00% | 5.84% | 13.64% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.06 | 0.06 | 0.23 | NA |
# of Estimates | 1 | 1 | 2 | NA |
Most Recent Consensus | 0.06 | 0.06 | 0.20 | NA |
High Estimate | 0.06 | 0.06 | 0.25 | NA |
Low Estimate | 0.06 | 0.06 | 0.20 | NA |
Year ago EPS | 0.06 | 0.04 | 0.14 | 0.23 |
Year over Year Growth Est. | 0.00% | 50.00% | 64.29% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 0 | 0 | 0 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.06 | 0.06 | 0.23 | NA |
7 Days Ago | 0.06 | 0.06 | 0.23 | NA |
30 Days Ago | 0.06 | 0.06 | 0.23 | NA |
60 Days Ago | NA | NA | 0.25 | 0.35 |
90 Days Ago | NA | NA | 0.25 | 0.35 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.06 | 0.06 | 0.23 | NA |
Zacks Consensus Estimate | 0.06 | 0.06 | 0.23 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.04 | 0.01 | 0.04 | 0.06 | NA |
Estimate | 0.05 | 0.04 | 0.05 | 0.05 | NA |
Difference | -0.01 | -0.03 | -0.01 | 0.01 | -0.01 |
Surprise | -20.00% | -75.00% | -20.00% | 20.00% | -23.75% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more